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Abstract
Background: Human bone marrow-derived mesenchymal stem cells (MSC) are adult progenitor cells with great
potential for application in cell-based therapies. From a cell-based therapy perspective, there are two limitations to
MSC use: (1) these therapies require large numbers of cells, and long-term expansion of MSC in vitro promotes
replicative senescence; and (2) patient variability is a challenge for defining MSC quality standards for transplantation.
This study aimed to determine whether low or high oxidative status of MSC correlate with changes in cell expansion
and differentiation potentials.
Methods: We investigated functional aspects of mitochondria, such as cell metabolic activity indicators and expression
of antioxidant enzymes. Furthermore, we tested if senescence-induced changes in oxidative status of MSC could be
counteracted by methylene blue (MB), an alternative mitochondrial electron transfer known to enhance cell
bioenergetics.
Results: MSC isolated from donors of the same age showed distinctive behavior in culture and were grouped as weak
(low colony-forming units (CFU) and a short life in vitro) and vigorous MSC (high CFU and a long life in vitro). In
comparison to weak MSC, vigorous MSC had oxidative status characterized by lower mitochondrial membrane
potential, lower mitochondrial activity, and fewer reactive oxygen species production, as well as reduced mitochondrial
biogenesis. Vigorous MSC had a significantly higher expansion potential compared to weak MSC, while no differences
were observed during differentiation. MB treatment significantly improved expansion and differentiation potential,
however only in vigorous MSC.
Conclusions: Together, these results demonstrate the importance of mitochondrial function in MSC in vitro, and that
cells with low oxidative status levels are better candidates for cell-based therapies.
Keywords: Human mesenchymal stem cells, Cell senescence, Cell differentiation, Antioxidant enzymes, Mitochondrial
biogenesis, Methylene blue
Background
Mesenchymal stem cells (MSC) are adult progenitor
cells associated with the musculoskeletal lineage, and are
characterized by fast expansion ability [1], differentiation
into several mesodermal phenotypes [2], and secretion
of trophic and immunomodulatory factors [3]. MSC can
be isolated from diverse adult tissues, including bone
marrow stroma [4]. The number of MSC in the bone
marrow might be reduced by diseases such as osteo-
porosis [5], leukemia [6], or lung and breast cancers [7].
Aging has also been proposed as an underlying cause of
MSC deficiency in the bone marrow; however, this is still
a matter of debate. While a decline in MSC number in
bone marrow stroma has been linked to increased donor
age in several papers [8, 9], others report the absence of
any correlation between the two factors [6, 10]. The
reasons for exhaustion of MSC in the bone marrow are
still debated; however, oxidative stress has been shown
to be one of the major factors influencing tissue aging
[11, 12], and as such merits in-depth investigation.
Oxidative stress exists in every cell, but as a patho-
logical condition it is based on the disruption of the
physiological equilibrium between oxidant and antioxi-
dant species, which leads to abnormal intracellular
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accumulation of reactive oxidative species (ROS).
ROS—such as superoxide radicals and hydrogen peroxi-
de—has a detrimental impact on biomolecules, cells, and
tissues [13], contributing over time to the development
of some of the more common diseases occurring with
aging, such as cardiovascular disease, diabetes, and
cancer [14]. In a healthy homeostasis, ROS are balanced
by the action of antioxidant enzymes, the expression of
which declines with aging [15]. Furthermore, young and
functional cells maintain a delicate equilibrium between
fission and fusion of mitochondria [16], and defective
mitochondrial turnover and dynamics has been imple-
mented in the process of aging [17]. Equilibrium is also
fundamental at the molecular level in the mitochondria,
especially between nuclear and mitochondrial encoded
proteins. Stoichiometric imbalance in these proteins
leads to the activation of the mitochondrial unfolded
protein response (UPRmt) which protects mitochondria
from further stress and promotes prolongation of the
lifespan [18]. Lifespan extension is also related to in-
creased levels of an electron carrier, the metabolic
cofactor NAD+ [19, 20]. NAD+ supports the deacetyla-
tion activity of sirtuin-1 (SIRT1) which promotes the
expression of genes involved in mitochondrial biogen-
esis, such as peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC-1α) [21]. Since activa-
tion of SIRT1 depends on NAD+ levels, increasing its
levels or supplying an additional electron donor could
counteract mitochondrial dysfunction.
Methylene blue (MB), a diaminophenothiazine, is a
functional electron donor due to its low redox potential
[22], and the activity of MB within the mitochondria
depends on NAD(P)H dehydrogenases resulting in the
formation of its reduced form, MBH2 (leucomethylene
blue) [23]. It acts as a substitute electron carrier that can
bypass the compromised electron transport chain at
proximal complexes, interacting with complex I and
cytochrome c [24]. The beneficial role of MB was
demonstrated in a mouse model of Hutchinson-Gilford
progeria—a premature aging syndrome—where MB
rescued damaged mitochondria and prolonged the in
vitro lifespan of cell cultures to levels similar to that of
the wild-type control [25].
Here, we hypothesized that the structure and function
of mitochondria degenerate during the process of in vitro
aging of human MSC, and our aim was to correlate the
oxidative status of MSC to their expansion potential. For
this purpose, MSC were split into weak and vigorous cul-
tures based on their in vitro fitness. Then, we investigated
some structural and functional features of mitochondria
during cellular aging, including cell metabolic activity
indicators and antioxidant enzyme protein expression. We
also tested whether degenerative changes in the oxidative
status could be counteracted by supplementation of MB.
Finally, we investigated the impact of MB on MSC differ-
entiation potential to determine if there is a correlation
between mitochondrial dysfunction and differentiation
to adipogenic, chondrogenic, and osteogenic lineages,
assessed by quantification of tissue-specific markers.
Methods
MSC isolation and expansion
Fresh bone marrow (BM) samples were obtained from
the iliac crest of the donors during surgery. MSC were
isolated from BM of six male donors (average age 65 ±
8 years; n = 3 per group). The BM aspirates were diluted
in 3.8% sodium citrate and phosphate-buffered saline
(PBS; Applichem, Axonlab, Baden, Switzerland) and then
filtered through a 100-μm cell strainer to remove clots
(Falcon, Faust, Schaffhausen, Switzerland). Mononuclear
cells were separated by H-Lympholyte Cell Separation
Media gradient centrifugation (density 1.077 g/mL;
Cedarlane, Bio Concept, Allschwil, Switzerland) in a
Leucosep tube (Huberlab, Reinach, Switzerland) at 800 g
for 15 min, washed with PBS, centrifuged again at 210 g
for 10 min and plated at a density of 1 × 105 cells/cm2 in
tissue culture flasks (TPP, Faust) in α-MEM, supple-
mented with 10% fetal bovine serum (FBS) (both Amimed,
Bio Concept), 100 units/mL penicillin and 100 mg/mL
streptomycin, and 2.5 μg/ml amphotericin B (both Gibco,
LuBioScience GmbH, Lucerne, Switzerland) at 37 °C in a
humid atmosphere containing 5% CO2. After 2 days, non-
adherent cells were discarded, whereas adherent cells were
cultured in growing medium consisting of DMEM/Ham’s
F12, supplemented with 10% FBS (both Amimed), 100
units/mL penicillin and 100 mg/mL streptomycin,
2.5 μg/ml amphotericin B (all Gibco) and 5 ng/ml re-
combinant basic fibroblast growth factor (bFGF;
Peprotech, LuBioScience), with medium changed three
times a week.
Colony forming assay
Freshly isolated cells from bone marrow (mononuclear
cells; 1 × 106) were plated in 10-cm Primaria cell-culture
dishes (Falcon) and cultured with growing medium.
After 14 days, cell colonies were washed with PBS, fixed
with 100% methanol, and stained with Giemsa solution
(all Applichem).
Long-term culture of MSC
MSC plated at a density of 1.6 × 103 cells/cm2 were
cultured with or without the addition of 200 nM MB
(Applichem) to the growing medium. Cultures were split
at 80–90% confluency and re-plated at the same cell
density. Cell number and cell diameter were measured with
the Scepter cell counter (Millipore, Milian, Nesselnbach,
Switzerland) at each passage. The population doublings
per passage (PDP) were calculated by the formula
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PDP = ln(nf/ni), where ni is the initial number of cells
and nf the final number of cells. The division rate for
each passage was calculated by dividing PDP by time. For
each donor, results per passage were pooled in three equal
groups, namely early, middle, and late passages (minimum
3 and maximum 6 passages per group depending on how
long the cell culture protracted).
Flow cytometry analysis of MSC markers
MSCs were sampled at 1 × 105 cells/tube to investigate the
proportion of CD44-, CD90-, and CD105-positive and
CD14-negative cells. Cells were incubated with CD14-
FITC (NB100-77759, Novus Biological, LuBioScience),
CD44-FITC (NBP1-41278, Novus Biological), CD90-FITC
(NBP1-96125, Novus Biological), and CD105-FITC
(MCA1557A488T, AbD Serotec, LuBioScience) antibodies
in PBS for 1 h at 4 °C, washed and resuspended in PBS.
Cell fluorescence was evaluated with FACScalibur flow
cytometer (Becton Dickinson) and data were analyzed
using FlowJo v.10.0 software (Treestar, Ashland, OR,
USA).
Senescence associated beta-galactosidase assay (SA-β-Gal)
SA-β-gal activity of MSC was determined at different
passages using a fluorescence-based method and flow
cytometry, as described previously [26, 27]. In brief, cells
were pre-treated for 1 h with 100 nM bafilomycin A1
(Sigma, Buchs, Switzerland), which inhibited lysosomal
acidification, and then incubated for 1 h with 33 μM
5-dodecanoylaminofluorescein di-β-D-galactopyranoside
(C12FDG, Sigma), a fluorogenic substrate for β-galacto
sidase. Data were analyzed with FlowJo software.
Cell metabolic activity
At each passage, cell activity was assessed by resazurin
reduction assay. MSC were incubated in resazurin solu-
tion (15 ng/mL resazurin, 2.5 ng/mL methylene blue,
0.1 mM potassium ferricyanide, 0.1 mM potassium ferro-
cyanide (all Applichem) in growing medium without
bFGF) for 3 h and bottom well fluorescence absorbance
was measured (λex = 535 nm and λem = 595 nm) using a
Multimode Detector (DTX 880; Beckman Coulter,
Nyon, Switzerland). Results were normalized to the
amount of cells.
Mitochondrial membrane potential and superoxide
mitochondrial accumulation
MSC were tested with the JC1-Mitochondrial Membrane
Potential Assay Kit (Abnova, LuBioScience) which con-
tains tetraethylbenzimidazolylcarbocyanine iodide (JC-1;
LucernaChem, Lucerne, Switzerland), a cationic dye that
accumulates in energized mitochondria. At low mito-
chondrial membrane potential JC-1 is predominantly a
monomer (λex = 535 nm), while at high mitochondrial
membrane potential the dye aggregates (λex = 595 nm).
Cells were incubated for 15 min with JC-1 in growing
medium, followed by three washes with PBS. Mitochon-
drial membrane potential was calculated as the ratio
between JC-1 aggregate and monomer.
The production of superoxide by mitochondria was
measured using the MitoSOX Red reagent (Thermo
Fisher, Zug, Switzerland). Cells were incubated for
10 min with 5 μM MitoSOX Red and 1× SYBR (Thermo
Fisher) in HBSS (Gibco), followed by three washes with
HBSS. The oxidized product is highly fluorescent upon
binding to nucleic acid. Bottom well fluorescence
absorbance was measured using a Multimode Detector
for both methods and results were normalized on RFU
of SYBR.
RNA isolation, cDNA synthesis, and real-time PCR
Total RNA was isolated from MSC microcarrier con-
structs after 28 days in culture. Constructs were homog-
enized using Dispomix in RNA lysis buffer of Aurum
Total Mini Kit (Bio Rad, Reinach, Switzerland), following
the manufacturer’s instructions with the modification of
adding 2 μl polyacryl carrier (LucernaChem) in the kit
lysis buffer. cDNA was prepared using VILO cDNA
Synthesis Kit (Invitrogen).
Real-time (RT)-PCR reactions consisted of the primers
listed in Table 1 at a concentration of 250 nM, 5 μl
cDNA template, and IQ SYBR Green Supermix (Bio
Rad). Specific products were amplified by a quantitative
PCR system (CFX96™ Real Time System, Bio Rad). RT-
PCR was carried out with the following settings:
denaturation 95 °C 3 min (1 cycle), 95 °C 15 s, 60 °C
20 s, and 72 °C 20 s (35 amplification cycles) in a final
volume of 20 μl in 96-well plates (Bio Rad). Melting
curve analysis was performed after each reaction. Rela-
tive gene expression was determined using the 2−ΔΔCt
method and the results were normalized to the expres-
sion of GAPDH.
DNA isolation and determination of telomere length and
mtDNA copy number
Telomere length was determined by real-time PCR, as
previously described [28]. Briefly, genomic DNA (from
1 × 106 cells) of MSC at early, middle, and late passages
was isolated using the appropriate DNA purification kit
[29] (Gentra PureGene Cell Kit; Qiagen, Hombrechtikon,
Switzerland). gDNA samples were quantified and run in
triplicate in a 96-well plate in a quantitative PCR system.
The sequences of the telomere and 36B4 primers are
listed in Table 1. The real-time PCR program consisted of
initial denaturation at 95 °C for 5 min, followed by 32
PCR cycles at 95 °C for 10 s and 60 °C for 30 s. Melting
curve analysis was carried out for each reaction and stand-
ard curves were fitted for both telomere DNA and 36B4
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DNA. For each sample, values were calculated as a ratio of
telomere DNA to 36B4 DNA, and data were converted to
base pairs based on standard curves of appropriate
oligomers.
Mitochondrial DNA (mtDNA) copy number, relative
to the diploid chromosomal DNA content, was quanti-
fied using a quantitative PCR system [30]. The relative
mtDNA copy number was measured by normalizing the
expression of NADH dehydrogenase subunit-1 (ND1)
gene (mtDNA-encoded) and cystic fibrosis (CF) gene
(nuclear DNA-encoded). Primer sequences are listed in
Table 1. PCR was carried out with the following settings:
denaturation 95 °C for 5 min, followed by 95 °C for 10 s
and 63.7 °C for 30 s (40 amplification cycles) in a final
volume of 20 μl in 96-well plates (Bio Rad).
Immunoblot analyses
Whole protein content was isolated from MSC at early
and late passages, cultured with or without MB. Cells
were lysed in 150 mM NaCl, 1% Triton X-100, 0.5% Na
deoxicholate, 0.1% SDS, 50 mM Tris, pH 8.0 (all
Applichem) and phenylmethane sulfonyl fluoride (PMFS;
Sigma) for 30 min, centrifuged at 800 g for 10 min (both
at 4 °C), and protein extracts (25 μg) were fractionated
by Mini-Protean TGX 4–15% gradient polyacrylamide
gels, and semi-dry blotted to a nitrocellulose membrane
(both Bio Rad). The nitrocellulose membranes were
incubated with mouse monoclonal antibodies against
Total OXPHOS Rodent WB Antibody Cocktail (1:1000;
ab110413, Abcam), Cu/Zn-SOD (1:2000; rabbit, NBP2-
24915SS, Novus Biological), Mn-SOD2 (1:2000; mouse,
AM7579A, Abgent, LuBioScience), catalase (1:5000;
rabbit, NBP2-24916SS, Novus Biological), and house-
keeping gene actin (1:5000; mouse, 3700, Cell Signaling,
Bio Concept). Blocked membranes were probed over-
night at 4 °C with primary antibodies diluted in 5% milk
(Rapilait, Migros, Switzerland) in PBS, followed by HRP-
conjugated mouse secondary antibody or rabbit second-
ary antibody (both 1:10,000; Bethyl, LuBioScience) in 5%
milk in PBS for 1 h at room temperature. Membranes
were developed with LumiGLO Reserve Chemilumines-
cent Substrate Kit (LumiGlo Reserve KPL, Bio Concept).
Acquisition was performed with a digital SLR camera
(Nikon D600, Nikon, Zürich, Switzerland), and the
results were normalized to the relative amount of actin.
MSC in vitro differentiation into osteogenic,
chondrogenic, and adipogenic lineages
MSC cultures were stimulated with the appropriate
differentiation medium according to the conditions
described below.
Chondrogenic differentiation
Collagen type I cubes (Biopad, Euroresearch, Italy) were
used as a scaffold to support cellular differentiation [31].
MSC (8 × 105) were seeded per cube and kept for 30 min
to allow adhesion before the addition of chondrogenic
medium. MSC-collagen constructs were cultured for
3 weeks in chondrogenic medium consisting of advanced
DMEM+GlutaMAX (Gibco), 2.5% FBS, 100 units/mL
penicillin, 100 mg/mL streptomycin, 2.5 μg/mL ampho-
tericin B, 40 ng/mL dexamethasone (Sigma), 50 μg/mL
ascorbic acid 2-phosphate (Sigma), 35 μg/mL L-proline
(Sigma), 1× Insulin-Transferrin-Selenium X (Gibco),
Table 1 Human genes used in quantitative real-time PCR
Gene Primer nucleotide sequence (5′→ 3′) Amplicon (bp)
Housekeeping gene
GAPDH
F - TGGACTCCACGACGTACTCA 102
R - GGAAGCTTGTCATCAATGGAA
Mitochondrial biogenesis
POLG F - GCTGGTGGAAGAGCGTTACTC 241
R - GAAGCTGCTTAGCCCTGAGAT
POLG2 F - GGTTTGGGGGTCGAGTAGATG 186
R - TTCCACTTAGGAAATGCCTTCTC
NRF1 F - AACAAAATTGGGCCACGTTACA 291
R - TCTGGACCAGGCCATTAGCA








F - CCACATCCTACCCAACATCAAG 93
R - CACAAGGCCGTTGACTTTTAGA
Mitochondrial chaperones
PHB F - CACAGAAGCGGTGGAAGC 96
R - ATGGCCGCCTITTTCTGT
PHB2 F - TGCTGAACCTACAGGATGAAA 77
R - TGGTGACTAGGCTCATITCTTACC









36B4 F - CAGCAAGTGGGAAGGTGTAATCC 75
R - CCCATTCTATCATCAACGGGTACAA
mtDNA copy number
ND1 F - GGAGTAATCCAGGTCGGT 265
R - TGGGTACAATGAGGAGTAGG
CF F - AGCAGAGTACCTGAAACAGGAA 482
R - AGCTTACCCATAGAGGAAACATAA
bp base pair, F Forward, mtDNA mitochondrial DNA, R Reverse
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and 10 ng/ml transforming growth factor (TGF)-β1
(Peprotech).
Glycosaminoglycan (GAG) accumulation was deter-
mined as a chondrogenic marker. GAG accumulation was
quantified with alcian blue binding assay after 6 h digestion
of two constructs per sample at 60 °C with 125 μg/mL
papain (Sigma-Aldrich) in 5 mM L-cysteine-HCl (Fluka),
5 mM Na-citrate, 150 mM NaCl, and 5 mM EDTA (all
AppliChem). GAG accumulation was determined by bind-
ing to alcian blue (Fluka, Sigma) and quantified using
chondroitin sulphate (Sigma) reference standards [32].
Osteogenic differentiation
MSC in monolayer at a density of 5 × 103 cells/cm2 were
differentiated in STEMPRO® Osteogenesis Differenti-
ation Kit (Gibco) for 3 weeks. Calcium content was
determined using the Calcium CPC LiquiColor test kit
(StanBio, Schwetzingen, Germany). Cells were washed
with PBS, incubated with 0.5 N HCl for 30 min at room
temperature and then with O-Cresolphthalein complex
one in alkaline solution. Calcium concentration was
measured and quantified with standards.
Adipogenic differentiation
MSC were cultured in monolayers at a density of 2.5 ×
104 cells/cm2 under two different culture conditions:
adipogenesis inducing medium—basal medium (DMEM/
Ham’s F12+ GlutaMAX, 2.5% FBS, 100 units/mL penicil-
lin, 100 mg/mL streptomycin, 2.5 μg/mL amphotericin B)
supplemented with 1 μM dexamethasone, 0.5 mM 3-
isobutyl-1-methylxanthine, 0.5 mM indomethacin, and
170 mM insulin (all Sigma)—and adipogenesis main-
tenance medium—basal medium supplemented with
170 mM insulin. Lipid droplets were revealed by staining
with Oil Red O (Sigma), and dye content was quantified
after isopropanol elution and spectrophotometry by meas-
uring the absorbance at 520 nm.
Statistical analysis
Results are presented as mean ± SEM. Two tailed
Student’s t test was used to determine significant differ-
ences between samples. For all tests, p < 0.05 was con-
sidered significant.
Results
Cell culture fitness comparison between MSC
MSC in vitro fitness was evaluated based on their ability
to form colonies (colony-forming unity assay (CFU);
Fig. 1a and b) and cumulative population doublings
(CPD; Fig. 1c), and subsequently split in two groups:
weak and vigorous. At the beginning of the culture,
MSC belonging to the vigorous group formed 2.3-fold
more colonies (102 colonies) compared to the weak
group (43 colonies; p < 0.05). Additionally, CPD were
almost double in the vigorous group (28 divisions) in
comparison to the weak group (15 divisions; p < 0.05).
Furthermore, MSC were also characterized by flow
cytometry analysis (Fig. 1d) with the positive MSC
markers CD44, CD90, and CD105 and with the negative
monocyte marker CD14. Compared to early passages,
CD90 expression was decreasing by 52% in weak MSC
(p < 0.05) and by 38% in vigorous MSC at late passages
(Table 2), while the other markers were constitutively
expressed.
Mitochondrial activity of MSC cultures
Cell metabolic differences between MSC groups were
assessed by comparing mitochondrial activity (resazurin
Fig. 1 MSC cultures were separated based on their cell fitness in vitro
into weak and vigorous cell cultures. a Colonies were stained with
Giemsa (colony-forming unit assay (CFU)) and b counted at the
beginning of in vitro cultures, while c MSC cumulative population
doublings (CPD) were calculated at the end of cell cultures (n = 3;
values represent the mean ± SEM). *p < 0.05. Expression of the
MSC-positive markers CD44 (orange line), CD90 (dark green line), and
CD105 (light green line), and the negative marker CD14 (blue line) was
tested by flow cytometry analysis (d), as shown by a representative
sample (grey line= unstained control). MNC mononuclear cells
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oxidative reaction; Fig. 2a), number of mitochondrial
DNA copies (mtDNA; Fig. 2b), superoxide radical
production (Fig. 2c), and changes in mitochondrial
membrane potential (Δψm; Fig. 2d). Cells belonging to
the vigorous group showed no significant changes across
passages in their mitochondrial activity (22% increase)
and mtDNA copies (16% increase). On the other hand,
at late passages, cells in the weak group doubled their
mitochondrial activity (p < 0.05) and mtDNA copies in
comparison to early passages. At early passages, super-
oxide radical (O2
–) production and Δψm were higher (7%
and 18%, respectively) in the weak group compared to the
vigorous group (p < 0.05). At late passages, in the weak
group O2
– production significantly increased further by
13% (p < 0.05), while in the vigorous group only by 4%.
Δψm of cells in the weak group did not change signifi-
cantly, while in the vigorous group it significantly in-
creased to reach the levels of the other group (p < 0.05).
Quantitative real-time PCR was used to assess the
expression of genes linked to mitochondrial homeostasis:
DNA polymerase gamma-2 (POLG2; Fig. 2e), mitochon-
drial transcription factor A (TFAM; Fig. 2f ), peroxisome
proliferator-activated receptor gamma coactivator 1-
alpha (PGC-1α; Fig. 2g), and mitochondrial ribosomal
protein S5 (MRPS5; Fig. 2h) at the beginning and at the
end of cell culture. At early passages, POLG2, TFAM,
and MRPS5 gene expressions were significantly higher
(67%, 48%, and 30%, respectively) in cells belonging
to the weak group compared to the vigorous group
(p < 0.05). The TFAM expression difference between the
two groups was also preserved at late passages (p < 0.05).
At late passages, POLG2 expression increased significantly
in both groups compared to early passages (p <
0.05)—57% in the weak and 93% in the vigorous groups.
PGC-1α expression did not differ significantly at early
passages between groups, but doubled in the weak group
at late passages (p < 0.05), while in the vigorous group it
did not change. No gene expression differences were
found for DNA polymerase gamma (POLG), nuclear
respiratory factor 1 (NRF1), and peroxisome proliferator-
activated receptor gamma coactivator 1-beta (PGC-1β)
(data not shown).
Differential expansion potential of MSC cultures
Expansion potential of MSC cultures was assessed by
cell division time (Fig. 3a), telomere length (Fig. 3b), and
cell senescence (Fig. 3c). Vigorous MSC cultures were
characterized by significantly shorter cell division time
in the late passages, compared to weak cells (114 hours/
division vs. 270 hours/division, p < 0.05). Cells belonging
to the vigorous group started with significantly longer
telomeres (7200 bp) compared to the other group
(2400 bp, p < 0.05). This gap was reduced at late passages
(4700 bp vigorous versus 3100 bp weak) but was still
significantly divergent (p < 0.05). Despite these clear-
cut differences in cell fitness, the two cell groups
showed similar cell senescence patterns across all cell
culture passages.
Methylene blue influence on expansion potential of low
oxidative status MSC
MSC were cultured with and without 200 nM methylene
blue (MB), an active electron donor/acceptor. With the
addition of MB to the cultures, cells in the vigorous
group showed reduced division times by 8%, 18% (p <
0.05), and 21% (p < 0.05) in early, middle, and late pas-
sages, respectively (Fig. 4a). MB also reduced by 28%
(middle passages) and by 18% (late passages) the number
of senescent cells in the population (p < 0.05), again only
in the vigorous group (Fig. 4b). In the weak group, MB
increased the division time (not significantly) by 8%, as
well as the number of senescent cells by 22%. These
differences were reflected in increased CDP in vigorous
MSC by 17% (p < 0.05) with MB addition, while no
changes were observed in the weak group (Fig. 4c). MB
had no influence at any time point on telomere length
and mtDNA copies of both MSC groups (data not
shown).
Although MB distinctly affected the cell division poten-
tial of the MSC groups, the cell mitochondrial activity
(Fig. 4d) and Δψm (Fig. 4e) followed the same pattern in
both groups. Addition of MB to cultures increased the
mitochondrial activity on average by 20% and Δψm by
10%. Western blotting analysis of the relative levels of the
five oxidative phosphorylation complexes showed in-
creased expression of NADH:Ubiquinone Oxidoreductase
Subunit B8 (CI-NDUFB8) by MSC in the late passages.
Furthermore, the ratio between the nuclear-encoded gene
succinate dehydrogenase enzyme, subunit B (CII-SDHB),
and the mitochondrial-encoded gene cytochrome-c
oxidase-1 (CIV-MTCO1) showed a twofold increase in
cells of the weak group at late passages, while the levels in
the vigorous group were stable (Fig. 4f and g). MB
lowered the ratio in the weak group to a level equal
to that in early passages, but did not affect cells in
the vigorous group. At late passages, MB induced a
decrease in the gene expression of genes linked to
Table 2 Flow cytometry analysis of MSC markers at early and
late passages
Surface Weak MSC Vigorous MSC
markers Early Late Early Late
CD14– 99.4 ± 0.2 99.6 ± 0.1 99.5 ± 0.4 98.8 ± 0.3
CD44+ 100.0 ± 0.1 100.0 ± 0.2 99.7 ± 0.5 100.0 ± 0.1
CD90+ 83.4 ± 15.7 31.0 ± 21.6* 95.2 ± 3.8 57.3 ± 49.3
CD105+ 98.0 ± 1.7 98.7 ± 1.8 99.0 ± 0.8 99.5 ± 0.2
Values are shown as mean % expression ± SD; n = 3 per group
*p < 0.05 compared to early passages
MSC mesenchymal stem cells
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mitochondrial biogenesis (Fig. 4h) and mitochondrial
protein folding (Fig. 4i) in both groups. MSC expression
of POLG, POLG2, TFAM, and NRF1 was significantly
reduced by 30–40% upon addition of MB (p < 0.05).
Similarly, mitochondrial chaperones prohibitin-2 (PHB2)
and MRPS5 were significantly reduced by 40% (p < 0.05).
No significant reductions were observed in the expression
of PGC-1α, PGC-1β, or prohibitin (PHB).
Fig. 2 Comparison of cell oxidative status of MSC. a Cell mitochondrial activity (measured by resazurin reduction assay), b mitochondrial DNA
(mtDNA) copies (quantified by PCR), c mitochondrial superoxide production (MitoSOX), and d membrane potential (JC-1 staining) were measured
in MSC during cell expansion (n = 3; values represent the mean ± SEM). *p < 0.05). Gene expression of e DNA polymerase gamma-2 (POLG2),
f mitochondrial transcription factor A (TFAM), g peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), and
h mitochondrial ribosomal protein S5 (MRPS5) by MSC was analyzed in all samples at early and late passages (n = 3; values represent the
mean ± SEM). Gene expression was normalized to GAPDH and normalized to expression in early passages of vigorous MSC. *p < 0.05
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Methylene blue reduces superoxide radical production of
high oxidative status cells
Higher metabolic rates have been associated with accumu-
lation of toxic reactive oxygen species as a by-product.
Measurements of the intracellular levels of O2
– (Fig. 5a)
showed a significant 13% increase in accumulation in late
passages in the weak MSC group (p < 0.05). MB signifi-
cantly reduced the production of O2
– by ~10% (p < 0.05).
No significant changes in O2
– production were observed in
the vigorous group, either at late passages or with MB.
Production of O2
– shared the same expression pattern of
the cytosolic enzyme (copper/zinc) superoxide dismutase
(Cu/ZnSOD). In fact, protein levels of Cu/ZnSOD in-
creased at late passages in the weak MSC group, while in
the vigorous MSC group they did not (Fig. 5b and c). Pro-
tein expression of the mitochondrial enzyme (manganese)
superoxide dismutase (MnSOD) was stable across pas-
sages, but was more than doubled by MB in the vigorous
group. Catalase protein expression was similar between
groups and passages (data not shown).
Methylene blue improves MSC differentiation
MSC were differentiated to adipogenic, chondrogenic,
and osteogenic lineages and results were evaluated by
formation of fat deposits and accumulation of proteogly-
can and calcium, respectively. MB had no effect on
differentiation of weak MSC (data not shown), while it
improved differentiation to fat and cartilage by vigorous
MSC at late passages (Fig. 6). MB significantly increased
adipogenesis and chondrogenesis by approximately 50%
(p < 0.05), but had no impact on osteogenesis. The differ-
entiation potential between weak and vigorous MSC was
similar both at early and late passages (data not shown).
Discussion
The free radical theory of aging proposes that cumulative
damage by free oxygen radicals is the basic reason for
cellular and tissue aging. In this study, we showed that
MSC isolated from donors of similar age had distinct in
vitro expansion potential which mirrored underlying dif-
ferences in mitochondrial oxidative status.
MSC were divided into two groups, weak and vigorous,
based on their fitness in culture. More in-depth analysis
demonstrated differences between the mitochondrial
function indicators of the MSC: changes in mitochondrial
activity, mtDNA copies, superoxide radical (O2
–) produc-
tion, mitochondrial membrane potential (Δψm), mitonuc-
lear protein imbalance, and expression of transcription
factors involved in mitochondrial biogenesis. At early pas-
sages, vigorous MSC had lower Δψm and O2
– production,
and expressed lower levels of mitochondrial biogenesis
genes, such as POLG2 and TFAM. All these parameters
together defined a higher level of cell fitness, further indi-
cated by significantly longer telomeres, reduced loss of
CD90+ cells, faster division rate, and longer viability in
culture. At late passages, vigorous MSC stabilized their
metabolic activity at lower levels: fewer mitochondria
reflected by fewer mtDNA copies, and consequently de-
creased production of O2
–. Conversely, weak MSC signifi-
cantly increased their metabolic activity with culture time,
by increasing the number of mitochondria and O2
–, as well
as by a rising gene expression of POLG2 and PGC-1α.
Although no difference in the progression of replicative
senescence was observed between the two MSC groups,
these data indicate an energetic dysfunction which affects
the long-term lifespan of cells in culture, and shows the
limitations of the standard test of replicative senescence
when such tests are used as a substitute for cell quality
assessment.
Aging of mitochondria is influenced by several mainten-
ance and turnover biological processes. High energetic
rates result in accumulation of reactive oxygen species
(ROS) which are detrimental for cell components; for
instance, mtDNA is very susceptible to oxidative damage
[13]. At higher levels, the same is true for high energy
consuming tissues, such as the heart and brain, ultimately
leading to the formation of damage in tissues and organs
[33]. On the other hand, low levels of ROS are well known
to trigger an adaptive hormetic response, generating a
stress resistant reaction and increased cell longevity [34].
Successful aging has also been related to functional mito-
chondrial dynamics, where centenarians were shown to
Fig. 3 Expansion potential of MSC measured by a cell division time, b telomere length, and c cellular senescence (C12FDG intensity measured by
FACS) analyzed in weak and vigorous MSC cultures during cell expansion (n = 3; values represent the mean ± SEM). *p < 0.05
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Fig. 4 (See legend on next page.)
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have high rates of mitochondrial autophagy [35]. At the
molecular level, mitochondrial protein turnover has been
associated with extension of longevity by activating the
mitochondrial unfolded protein response (UPRmt). Mito-
chondrial misfolded proteins activate chaperones and
proteases in order to re-establish the proteostasis balance,
promoting a stronger response to stress by the cells [36].
Although a dysfunctional ubiquitin-proteasome system
and high rate of protein oxidative damage are among the
main causes, UPRmt activation is also elicited by the re-
duction in the gene expression of mitochondrial ribosomal
protein S5 (MRPS5), which is involved in translation of
mtDNA-encoded proteins. In fact, 50% downregulation of
MRPS5 expression in mice extended their lifespan by
~250 days and, in C. elegans, RNA inhibition of the homo-
log MRPS5 prolonged lifespan by 50% [37]. Also, in our
experimental setting, methylene blue (MB) downregulated
MRPS5 gene expression by ~40%; however, we could not
observe any peculiar UPRmt activation in MSC. Thus,
downregulation of MRPS5 alone could not explain the
increased MSC lifespan. Additionally, MB reduced gene
expression of MRPS5 in the weak MSC without influen-
cing their expansion potential.
MB is a synthetic dye with several interesting features:
it is readily available, inexpensive, and approved for
medical use. Since its first application as an anti-malarial
drug, nowadays MB is used in the treatment of
methemoglobinemia [38], cyanide poisoning [39], and
ifosfamide-induced encephalopathy [40]. Furthermore,
MB enhances mitochondrial oxidative phosphorylation
and reduces anabolism in glioblastomas, leading to a
decrease in cancer cell proliferation [41]. In August
2016, 86 clinical trials involved MB use, ranging from
treatment of pain to bipolar disorder (clinicaltrials.gov).
The MB mechanism of action relies on its low redox
potential (close to that of oxygen) which allows MB to
act as an alternative electron acceptor within the mito-
chondria. Furthermore, MB has an antioxidant effect,
scavenging electrons from the proximity of the enzymes
where O2
– are produced [23]. We also observed an in-
crease in MSC metabolic activity in cultures with MB,
coupled with reduced ROS production. Recent observa-
tions suggest that an increase in the cell metabolic rate
is one of the effects of caloric restriction [42], the only
(See figure on previous page.)
Fig. 4 Effects of methylene blue (MB) on MSC in vitro cultures. Consequences of MB addition to cell cultures were evaluated by analyzing MSC
expansion potential (relative changes were normalized to MSC cultures without MB): a cell division time, b cellular senescence (C12FDG staining),
and c cumulative population doubling (CPD). The effects of MB on cell metabolism were analyzed by d cell mitochondrial activity (resazurin
reduction assay) and e mitochondrial membrane potential (JC-1 staining) (n = 3; values represent the mean ± SEM. *p < 0.05. f Western blot
analysis visualized changes in protein levels of respiratory enzymes in MSC cultured with or without MB, and g mitonuclear protein ratio was
quantified by dividing SDHB (nuclear-encoded gene) by MTCO1 (mitochondrial-encoded gene). h MB induced expression changes in mitochondrial
biogenesis and i chaperones genes in weak and vigorous MSC cultures at late passages (n = 3; values represent the mean ± SEM. Gene expression was
normalized to GAPDH and normalized to expression of MSC cultures without MB (dotted line). *p < 0.05
Fig. 5 Production of superoxide radicals (O2
–) and expression of
antioxidant enzymes during MSC expansion, with or without
methylene blue (MB) addition. a Quantification of superoxide
radicals was carried out by MitoSOX staining (n = 3; values represent
the mean ± SEM). *p < 0.05. b Mitochondrial (MnSOD) and cytosolic
superoxide dismutase (Cu/ZnSOD) Western blots were performed on
proteins isolated from the same samples, and c results were
normalized to actin
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known intervention that extends the lifespan of several
organisms.
We speculate that MB promotes the life extension of
MSC in a similar way, by promoting increases in cell
metabolic rate and mitochondrial membrane potential,
and lowering superoxide production. In parallel, we
propose that MB preserves functional mitochondria for a
longer time due to reduced biogenesis and increased ex-
pression of the mitochondrial superoxide dismutase. Simi-
larly, high metabolic rates promoted a lifespan extension
in mice, based on the “uncoupling to survive” theory [43].
In mitochondria, protons are transferred to the intramem-
brane space by the electron transport chain, eventually
promoting ADP phosphorylation. However, not all pro-
tons contribute to ATP formation, leaking through the
inner membrane. This process, known also as mitochon-
drial uncoupling, supports high cellular respiration and
low ROS and ATP production. We also observed that vig-
orous MSC were characterized by the lowest mitochon-
drial membrane potential. In a recent study, Sukumar et
al. showed that a low mitochondrial membrane potential
is a marker of hematopoietic stem cells [44]. Likewise, we
propose that MSC with lower mitochondrial membrane
potential possess enhanced stemness, which would explain
the longer in vitro lifespan. In contrast, in weak MSC, MB
could not induce any lifespan extension, although the ef-
fects of MB at the molecular level were coherent. We
speculate that mitochondria of these cells were in a more
advanced state of dysfunction which could not be rescued
by MB; hence, MB only has a preventative role.
Limitations of the study were the limited number of
donors per group and the absence of more specific tests,
such as mitochondrial proton conductance or accumula-
tion of mutations in mtDNA. We included only elderly do-
nors in the project because MSC isolated from older people
have lower in vitro expansion potential compared to youn-
ger donors [10], and so an increase in cell culture lifespan
would be more beneficial for them from a cell therapy
prospective. Furthermore, to avoid undesired alterations to
the endoplasmic reticulum and mitochondrial properties
promoted by the addition of bFGF to the culture media
[45], we controlled for this confounding effect by maintain-
ing a constant bFGF concentration among all groups.
Conclusion
In conclusion, we showed that the oxidative status can
be used as a predictor to reliably assess the quality of
expansion potential in MSC, independent of a donor’s
age. Preserved low oxidative status reduces the oxidative
stress in cells, maintaining a prolonged resourceful
homeostasis in MSC. We also demonstrated that the
addition of MB at a low dose to cell cultures increased
in vitro lifespan, but only for those cells with a low start-
ing oxidative status. MB also had the beneficial effect of
preserving the differentiation potential in vigorous MSC.
Therefore, this study opens the way for further research
on the importance of oxidative status in MSC homeosta-
sis, and future applications of MSC in cell-based therap-
ies. Together with our previously published score set for
cell senescence [46], analysis of oxidative status might
increase the cost-effectiveness and reduce the rate of
unsuccessful advanced cell therapies.
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Fig. 6 MSC differentiation potential of vigorous MSC at late passages was improved by methylene blue (MB) supplementation to cell culture. MSC
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